HCA 2Q26: Marketplace coverage reductions pressuring volumes; we lower LT EBITDA growth modestly

Research evidence excerpt

HCA 2Q26: Marketplace coverage reductions pressuring volumes; we lower LT EBITDA growth modestly

s growing outpatient network. Management notes ongoing litigation over CMS’s implementation

of these rules and expects politics in predominantly blue expansion states to soften the ultimate degree of coverage loss. That

said, they still view work requirements as a meaningful risk that will require active management.

Surgery volumes and elective demand - Surgical volumes were also a notable soft spot in the quarter, with inpatient

surgeries down ~2% and outpatient surgeries down ~3% YoY, driven largely by pressure in elective procedures. Emergency

inpatient surgeries (which make up ~2/3 of total inpatient cases) continued to grow at ~2% YoY. On the other hand, elective

inpatient surgeries declined around 6% (vs. 2% decline last year), reflecting the impact of ACA disenrollment and broader

affordability concerns. Management highlighted they are hearing from physicians that patient flow for elective work is “off”

as households feel economic pressure. They also noted that Medicare inpatient rule changes are shifting some cases from

inpatient to outpatient surgery, where HCA captures some but not all volume in a more fragmented market. Management is

responding by investing in OR infrastructure and ASC capabilities, optimizing throughput and reinforcing physician alignment.

Competitive positioning - Despite payer mix and policy headwinds, HCA believes its competitive positioning remains stable

to improving, supported by ongoing investments in beds, new hospitals, and an expanding outpatient footprint. Management

acknowledged isolated markets where competitors have made aggressive moves, but views these as localized rather than

evidence of broader share loss.